Elisabeth De Vries

News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me

Elisabeth De Vries
Apr 28, 2025, 10:35 | Blog
Raffaele Colombo: True honor to present at the educational session “Next generation antibody drug conjugates” at AACR25
Raffaele Colombo, Associate Director of Medicinal Chemistry at Zymeworks Inc. – shared on LinkedIn: "AACR25…
Apr 26, 2025, 19:50 | Blog
Paolo Tarantino: Our Cancer Discovery review article on 40 years of ADCs will be open access during AACR25
Paolo Tarantino, Clinical Research Fellow at Dana-Farber Cancer Institute, shared Cancer Discovery's post on X,…
Apr 24, 2025, 16:20 | Blog
Raffaele Colombo: Honored to be speaking at AACR25 educational session on next generation ADCs
Raffaele Colombo, Associate Director of Medicinal Chemistry at Zymeworks, posted on X, about recent paper…
Dec 25, 2024, 22:43 | History
Raffaele Colombo: A record 77 new ADCs entered clinical development in 2024
Raffaele Colombo, Associate Director of Medicinal Chemistry at Zymeworks Inc., shared a post on X…
Nov 7, 2024, 16:03 | Insight
The journey of ADCs is a story of perseverance
An article by Raffaele Colombo, Associate Director of Medicinal Chemistry at Zymeworks Inc., was recently…
Nov 5, 2024, 15:59 | Blog
Elizabeth McKenna: The November issue of Cancer Discovery is now online
Elizabeth McKenna posted on X: "I'm so excited that the November issue of Cancer Discovery…
Oct 26, 2024, 08:07 | Blog
Elisabeth de Vries and Timothy A. Yap welcome attendees to the EORTC-NCI-AACR Symposium
AACR shared on X: ''ENA Symposium 2024 cochairs Elisabeth de Vries and Timothy A. Yap…
Oct 25, 2024, 12:39 | Blog
The 36th EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics
AACR - American Association for Cancer Research shared a post on LinkedIn: "The 36th EORTC-NCI-AACR Symposium…
Oct 23, 2024, 14:45 | Blog
Paolo Tarantino: How do we build a new generation of safer and more active ADCs for treating cancer
Paolo Tarantino and Raffaele Colombo shared posts on X, about recent paper published in Cancer…
Sep 4, 2024, 09:54 | Insight
Lowest available rates for the EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics
AACR shared on X: "Register by September 4 to get the lowest available rates for…
Aug 28, 2024, 13:54 | Blog
Registration still open for the EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics
American Association for Cancer Research (AACR) shared a post on LinkedIn: "Register by September 4…
Oct 14, 2023, 22:16 | Blog
Paolo Tarantino: So much going on in the ADC field.
Paolo Tarantino, Medical Oncologist and Research Fellow at Dana-Farber Cancer Institute, shared the following on Twitter: "So…
Oct 2, 2023, 22:37 | Insight
Paolo Tarantino: Antibody drug conjugates (ADCs) are leading to relevant survival improvements for multiple types of cancer.
Paolo Tarantino, MD and researcher at the European Institute of Oncology and clinical research fellow…
All: 13 Posts: 1 - 100
Special Coverage